Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataHDFC
NAV₹40.2296₹23.6750
NAV date20 Nov 202620 Nov 2026
History10.9 years3.1 years
Expense ratio1.1%1.1%
Stars★★★★★★★★★★
Growth Score67.5094.50

Returns

Tata India Pharma & Healthcare FundHDFC Pharma and Healthcare Fund
1 month+9.87%+12.97%
3 months+1.12%+7.13%
6 months+7.63%+17.84%
YTD+13.73%+33.73%
1 year+11.82%+32.20%
3 years (CAGR)+18.74%+30.70%
5 years (CAGR)+16.00%—
10 years (CAGR)+15.95%—
Since launch+13.58%+31.83%

Risk

Tata India Pharma & Healthcare FundHDFC Pharma and Healthcare Fund
Volatility15.7%15.8%
Downside volatility10.0%8.5%
Sharpe0.781.53
Sortino1.232.86
Calmar1.122.06
Return / risk1.191.95
Deepest fall−19.84%−14.91%
Days to recover375126
Below its high+0.00%+0.00%

Against benchmark

Tata India Pharma & Healthcare FundHDFC Pharma and Healthcare Fund
Alpha−2.76%+7.54%
Beta1.000.97
R²90.2%85.0%
Up capture91.7%108.9%
Down capture101.4%71.0%
Tracking error4.9%6.1%
Information ratio−0.571.17
Treynor0.110.24

Consistency

Tata India Pharma & Healthcare FundHDFC Pharma and Healthcare Fund
Best 1-year+76.35%+67.01%
Middle 1-year+8.85%+23.25%
Worst 1-year−17.32%+1.71%
1-year periods with a loss29.0%0.0%
Middle 3-year+21.13%+30.22%
Positive months63.9%72.2%
Best day+3.34%+3.18%
Worst day−3.09%−3.61%
Worst 5% day−1.35%−1.51%
Positive days55.4%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundHDFC Pharma and Healthcare Fund
5-year XIRR+18.07%—
5-year value₹9,50,065—
3-year XIRR+13.31%+27.71%
1-year XIRR+18.41%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth